Status:
RECRUITING
Pressure Wire Guidance for Infrapopliteal Artery Interventions
Lead Sponsor:
Yonsei University
Conditions:
Chronic Limb-Threatening Ischemia
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
"• A prospective, single-center randomized controlled comparison trial. * A total of 100 patients with symptoms of chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular tr...
Detailed Description
1. Prospective, singlecenter, open label, randomized controlled study 2. Eligible patients with chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular treatment for anterior...
Eligibility Criteria
Inclusion
- Patient with chronic limb threatening ischemia (Rutherford 5)
- Anterior tibial artery or posterior tibial artery lesions ≥ 10 cm Age ≥19 years
Exclusion
- Acute limb ischemia
- Contraindication to antiplatelet or anticoagulation agents:
- Thrombocytopenia (platelet \<100,000/uL)
- Previous cerebral hemorrhage, GI bleeding, other reasons for increased bleeding risk within 6 months
- Pregnant women or women with potential childbearing
- Life expectancy \< 1 year
Key Trial Info
Start Date :
October 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 29 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06879561
Start Date
October 2 2025
End Date
August 29 2028
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Cardiology, Severance Cardiovascular hospital Department of Internal Medicine, Yonsei University College of Medicine
Seoul, South Korea